drugset / Trial / NCT03520543
[11C]Yohimbine PET Study of alpha2-AR
RandomizedParallel-groupOpen-labelBasic science
Summary
The main purpose of this study is to model tissue specific kinetics of \[11C\]Yohimbine in healthy male participants by positron emission tomography (PET) and the appropriate arterial input function (part A) ; to determine the reproducibility of measures (classical test-retest study, part B1) and to measure the blocking of \[11C\]Yohimbine uptake in the brain following single oral dose administration of clonidine (part B2).
Timeline
- Start
- 2018-05-21
- Primary completion
- 2018-07-21
- Completion
- 2019-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonidine | Other / unclassified | 0.15 mg | Oral |
| Subject | [11C]Yohimbine | Unknown | 370 mbq | Intravenous |
Indications
No indication recorded.